Home > Cashflow Statement > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
Cashflow Statement

SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

SAMRAT PHARMACHEM Last 5 Year Cashflow Statement History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹9.89 Cr₹2.52 Cr₹23 Cr₹24 Cr₹7.34 Cr
Adjustment ₹0.65 Cr₹0.03 Cr₹1.65 Cr₹1.19 Cr₹1.70 Cr
Changes In working Capital ₹-19 Cr₹9.83 Cr₹-24 Cr₹-5.78 Cr₹-1.99 Cr
Cash Flow after changes in Working Capital ₹-8.64 Cr₹12 Cr₹0.06 Cr₹19 Cr₹7.05 Cr
Cash Flow from Operating Activities ₹-10 Cr₹9.41 Cr₹-9.44 Cr₹17 Cr₹4.80 Cr
Cash Flow from Investing Activities ₹0.00 Cr₹-0.41 Cr₹-3.00 Cr₹-1.06 Cr₹-2.92 Cr
Cash Flow from Financing Activities ₹0.48 Cr₹-11 Cr₹9.60 Cr₹-1.95 Cr₹-1.89 Cr
Net Cash Inflow / Outflow ₹-9.62 Cr₹-2.19 Cr₹-2.84 Cr₹14 Cr₹-0.02 Cr
Opening Cash & Cash Equivalents ₹9.67 Cr₹12 Cr₹15 Cr₹0.24 Cr₹0.26 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹0.05 Cr₹9.67 Cr₹12 Cr₹15 Cr₹0.24 Cr

Compare Cashflow Statement of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹62.6 Cr -6.5% -4.7% -40.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

-6.5%

-4.7%

-40.6%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses